[at noodls] – ALBANY, N.Y., Nov. 19, 2012 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ALBANY, N.Y., Oct. 16, 2012 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Net sales of $83.4 million GAAP net loss of $0.02 per share; Adjusted (Non-GAAP) net income of $0.10 per share, a YOY 25% increase Integration of Navilyst Medical yielding significant cost savings Vortex … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ALBANY, N.Y. and NORWELL, Mass., Oct. 8, 2012 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative minimally invasive medical devices for vascular access, surgery, peripheral … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboard […]
